IR Calendar

Upcoming Events

2020 American Society of Hematology (ASH) Annual Meeting

Oral Presentation Title: A Phase I Study of Lintuzumab Ac225 in Combination with CLAG-M Chemotherapy in Relapsed/Refractory AML
Publication Number: 165
Session Name: 616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Advances in immunotherapeutics for management of AML
Session Date: Saturday, December 5, 2020
Presentation Time: 12:00 PM PT / 3:00 PM ET

Oral Presentation Title: Personalized Targeted Radioimmunotherapy with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] in Patients with Active Relapsed or Refractory Acute Myeloid Leukemia Results in Successful Donor Hematopoietic Cells Engraftment with the Timing of Engraftment Not Related to the Radiation Dose Delivered
Publication Number: 193
Session Name: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities
Session Date: Saturday, December 5, 2020
Presentation Time: 1:00 PM PT / 4:00 PM ET

Poster Title: Lintuzumab-225Ac in Combination with Venetoclax in Relapsed/Refractory AML: Early Results of a Phase I/II Study
Publication Number: 2875
Session Name: 616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II
Session Date: Monday, December 7, 2020
Presentation Time: 7:00 AM – 3:30 PM PT / 10:00 AM – 6:30 PM ET


Past Events

Alliance Global Partners' Virtual Healthcare Symposium

2020 Annual Meeting of Stockholders

Garden City, NY

CD33 Combination Trial KOL Call

Webcast

H.C. Wainwright 22nd Annual Global Investment Conference


More past events »